Baldwin Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
10,940
-36
-0.3% -$36.5K 1.18% 9
2025
Q4
$11.8M Sell
10,976
-103
-0.9% -$98.5K 1.33% 8
2025
Q3
$8.45M Buy
11,079
+1,505
+16% +$1.12M 0.97% 11
2025
Q2
$7.46M Buy
9,574
+176
+2% +$137K 0.9% 12
2025
Q1
$7.76M Buy
9,398
+511
+6% +$425K 0.93% 10
2024
Q4
$6.86M Buy
8,887
+533
+6% +$441K 0.89% 11
2024
Q3
$7.4M Buy
8,354
+195
+2% +$175K 0.93% 11
2024
Q2
$7.39M Buy
8,159
+9
+0.1% +$7.2K 1.01% 10
2024
Q1
$6.34M Sell
8,150
-448
-5% -$319K 0.86% 12
2023
Q4
$5.01M Sell
8,598
-143
-2% -$83.5K 0.78% 14
2023
Q3
$4.7M Sell
8,741
-279
-3% -$144K 0.79% 13
2023
Q2
$4.23M Sell
9,020
-800
-8% -$335K 0.7% 17
2023
Q1
$3.37M Buy
9,820
+1,998
+26% +$674K 0.6% 27
2022
Q4
$2.86M Buy
7,822
+674
+9% +$239K 0.52% 31
2022
Q3
$2.31K Buy
7,148
+358
+5% +$113K 0.47% 35
2022
Q2
$2.2K Sell
6,790
-572
-8% -$172K 0.42% 41
2022
Q1
$2.11K Sell
7,362
-130
-2% -$33.5K 0.32% 52
2021
Q4
$2.07K Buy
7,492
+535
+8% +$136K 0.32% 57
2021
Q3
$1.61M Sell
6,957
-300
-4% -$74K 0.28% 64
2021
Q2
$1.67M Buy
7,257
+95
+1% +$19.1K 0.28% 65
2021
Q1
$1.34M Buy
7,162
+690
+11% +$135K 0.24% 75
2020
Q4
$1.09M Buy
6,472
+125
+2% +$18.7K 0.22% 83
2020
Q3
$939K Buy
+6,347
New +$982K 0.22% 80

Other funds holding LLY

Baldwin Investment Management's LLY Position: Q1 2026 in Review

Baldwin Investment Management reduced its Eli Lilly (LLY) stake by 0.33% in Q1 2026, selling an estimated $36.5K and leaving 10,940 shares worth $10.1M. The position accounts for 1.18% of the portfolio, ranked #9.

Baldwin Investment Management first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $11.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Baldwin Investment Management held 10,940 shares of Eli Lilly worth $10.1M as of Q1 2026.
  • Baldwin Investment Management sold 36 Eli Lilly shares in Q1 2026, an estimated $36.5K.
  • Eli Lilly made up 1.18% of Baldwin Investment Management's portfolio in Q1 2026, its #9 holding.
  • Baldwin Investment Management first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • Baldwin Investment Management's Eli Lilly position peaked at $11.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.